Drug Development

Over the last 50 years, malaria parasites have developed resistance to seven drugs, but a new way to identify future antimalarials holds promise

An international collaboration has developed a new drug candidate that stops the malaria parasite from breaking down waste, resulting in fatal ‘molecular constipation’ and hope for new treatments

By targeting an essential nutrition pathway, researchers hope to develop drug targets against the bacterium that causes pneumonia

In what could be a new pathway for drug therapies to treat hypertension, a team of brain researchers have discovered that zinc plays a key role in lowering blood pressure

Many viruses – including coronaviruses ­– have a protective outer layer of proteins, fats and sugars. New research shows targeting sugar production has potential for broad-spectrum antiviral drugs

Associate Professor Reid is developing new drugs for epilepsy, focussing on both genetics and small molecules, to treat more people with epilepsy

As coronavirus case numbers surge, University of Melbourne experts explain why we have effective drugs for bacterial diseases, but relatively few for combating viruses

Finding existing drugs that are effective against COVID-19 is our best bet toward treatments, and the US buy-up of Remdesivir supplies highlights how urgent the race is

Researchers have developed a modified form of human insulin that successfully mimics the ultra fast-acting properties of cone snail venom insulin

Nobel Prize winner Professor Peter Doherty updates us on the latest COVID-19 drug and vaccine research, and how best to prepare for the next pandemic